Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 2.95 CAD 7.27% Market Closed
Market Cap: 95.2m CAD

Wall Street
Price Targets

MDP Price Targets Summary
Medexus Pharmaceuticals Inc

Wall Street analysts forecast MDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDP is 6.59 CAD with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.

Lowest
Price Target
3.48 CAD
18% Upside
Average
Price Target
6.59 CAD
124% Upside
Highest
Price Target
10.5 CAD
256% Upside
Medexus Pharmaceuticals Inc Competitors:
Price Targets
STAR
Strides Pharma Science Ltd
72% Upside
SNDL
Sundial Growers Inc
127% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
9% Downside
NEULANDLAB
Neuland Laboratories Ltd
21% Upside
KOTRA
Kotra Industries Bhd
18% Upside

Revenue
Forecast

Revenue Estimate
Medexus Pharmaceuticals Inc

For the last 12 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 37%. The projected CAGR for the next 3 years is 9%.

37%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's net income for the next 3 years is 112%.

N/A
Past Growth
112%
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDP's stock price target?
Price Target
6.59 CAD

According to Wall Street analysts, the average 1-year price target for MDP is 6.59 CAD with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.

What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
9%

For the last 12 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 37%. The projected CAGR for the next 3 years is 9%.

What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
29%

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 3 years is 29%.

What is Medexus Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
112%

The compound annual growth rate of Medexus Pharmaceuticals Inc's net income for the next 3 years is 112%.

Back to Top